Box score
Can-Fite BioPharma Ltd.
Reported $8.3M sold in a new Form D filed September 10, 2026 (Ramat Gan, outside the US).
- Biggest raise
- $8.3M filed Sep 10, 2026
- League
- Bio & Health Pharmaceuticals
- Based in
- Ramat Gan, outside the US
- Season rank
- #236 of 1,121 in the Bio & Health League; #2052 of 10,745 overall (2026)
- Entity
- Corporation
Form D filings since 2024 1
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2026-09-10 | New notice | $8.3M | $8.3M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 1536196.
Similar raises, 2026
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Visible Health Inc. rookie | Bio & Health | $9.7M |
| 2 | CollPlant Biotechnologies Ltd | Bio & Health | $9.2M |
| 3 | Pictura Bio US, Inc. rookie | Bio & Health | $9.1M |
| 4 | Pulsenmore Ltd. rookie provisional | Bio & Health | $7.5M |
| 5 | Vesalius Longevity Labs (SPV) Inc. | Bio & Health | $6.7M |
| 6 | Regentis Biomaterials Ltd. rookie | Bio & Health | $6.5M |